CIRM Funded Clinical Trials

Phase 1 Study of Autologous E-SYNC T Cells in Adult Participants with EGFRvIII+ Glioblastoma

Disease Area:

Investigator:

Dr. Hideho Okada

Institution:

University of California, San Francisco

CIRM Grant:

CLIN2-15562 (Active)

Award Value:

$10,927,618.00

Trial Sponsor:

University of California, San Francisco

Trial Stage:

Phase 1

Trial Status:

Launching

Targeted Enrollment:

N/A